Evidence map›Paper›PMID 37509476›Full record

ArticleBiomedicines2023

The

Svein Erik Moe, Fredrik A Erland, Siren Fromreide, Stein Lybak, Marianne Brydoy, Harsh N Dongre, Sophia M Dhayalan, Daniela-Elena Costea, Olav K Vintermyr, Hans Jørgen Aarstad

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Svein Erik MoeDepartment of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital (HUS), N-5020 Bergen, Norway.
Fredrik A ErlandDepartment of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital (HUS), N-5020 Bergen, Norway.
Siren FromreideDepartment of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway.
Stein LybakDepartment of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital (HUS), N-5020 Bergen, Norway.
Marianne BrydoyDepartment of Oncology, Haukeland University Hospital (HUS), N-5020 Bergen, Norway.
Harsh N DongreDepartment of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway.
Sophia M DhayalanDepartment of Pathology, Haukeland University Hospital (HUS), N-5020 Bergen, Norway.
Daniela-Elena CosteaDepartment of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway.ORCID 0000-0001-7673-0358
Olav K VintermyrDepartment of Pathology, Haukeland University Hospital (HUS), N-5020 Bergen, Norway.
Hans Jørgen AarstadDepartment of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway.
Haukeland University Hospital · NOUniversity of Bergen · NO

Funding

Western Norway Regional Health Authority F-12125
6 · The paper itself

Abstract

backgroundSomatic

objectiveTo study

methodsUsing a custom-made next-generation sequencing (NGS) panel on formalin-fixed, paraffin-embedded tumor tissue, we analyzed somatic

resultsOnly 2 of 44 patients with HPV-positive (HPV(+)) HNSCC had a

conclusionsOur observations show that

Indexed as

head and neck cancerHPVsinge-nucleotide polymorphismsomatic mutationTP53

Identifiers

PMID37509476
PMCPMC10376802
OpenAlexW4382279060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.